Agency for Healthcare Research and Quality Notice of Meeting, 41510 [07-3679]
Download as PDF
<![CDATA[
41510
Federal Register / Vol. 72, No. 145 / Monday, July 30, 2007 / Notices
This designation will become
effective on July 22, 2007, unless
Congress provides otherwise prior to the
effective date. After this effective date,
HHS will publish a notice in the
Federal Register reporting the addition
of this class to the SEC or the result of
any provision by Congress regarding the
decision by HHS to add the class to the
SEC.
FOR FURTHER INFORMATION CONTACT:
Larry Elliott, Director, Office of
Compensation Analysis and Support,
National Institute for Occupational
Safety and Health (NIOSH), 4676
Columbia Parkway, MS C–46,
Cincinnati, OH 45226, Telephone 513–
533–6800 (this is not a toll-free
number). Information requests can also
be submitted by e-mail to
OCAS@CDC.GOV.
John Howard
Director, National Institute for Occupational
Safety and Health.
[FR Doc. 07–3686 Filed 7–27–07; 8:45 am]
BILLING CODE 4160–17–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on PROD1PC66 with NOTICES
In accordance with section 10(d) of
the Federal Advisory Committee Act (5
U.S.C., Appendix 2), announcement is
made of a Health Care Policy and
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b (c)(6). Grant
applications for the Announcement of
Availability of Funds for Grants
regarding Minority Research
Infrastructure Support Program (M–
RISP) applications are to be reviewed
and discussed at this meeting. These
discussions are likely to reveal personal
information concerning individuals
associated with the applications. This
22:24 Jul 27, 2007
Jkt 211001
Dated: July 23, 2007.
Carolyn M. Clancy,
Director.
[FR Doc. 07–3679 Filed 7–27–07; 8:45 am]
BILLING CODE 4160–90–M
Agency for Healthcare Research and
Quality Notice of Meeting
VerDate Aug<31>2005
information is exempt from mandatory
disclosure under the above-cited
statutes.
SEP Meeting on: Minority Research
Infrastructure Support Program (M–
RISP).
Date: August 23, 2007 (Open on
August 23 from 2 p.m to 2:15 p.m. and
closed for the remainder of the meeting).
Place: John M. Eisenberg Building,
AHRQ Conference Center, 540 Gaither
Road, Rockville, Maryland 20850.
Contact Person: Anyone wishing to
obtain a roster of members, agenda or
minutes of the non-confidential portions
of this meeting should contact Mrs.
Bonnie Campbell, Committee
Management Officer, Office of
Extramural Research, Education and
Priority Populations, AHRQ, 540
Gaither Road, Room 2038, Rockville,
Maryland 20850, Telephone (301) 4271554.
Agenda items for this meeting are
subject to change as priorities dictate.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
Privacy Act of 1974; Retraction of a
New System of Records
Department of Health and
Human Services (HHS), Centers for
Medicare & Medicaid Services (CMS).
ACTION: Notice of retraction of a new
system of records.
AGENCY:
SUMMARY: The Centers for Medicare &
Medicaid Services CMS inadvertently
published a new system of records titled
‘‘Post Acute Care Payment Reform/
Continuity of Assessment Report and
Evaluation Demonstration and
Evaluation (PAC–CARE)’’ System No.
09–70–0569 in the Federal Register (FR)
on Thursday, April 19, 2007 (72 FR
19711). CMS is withdrawing the notice
due to comments received that a routine
use disclosure provision necessary to
carry out essential parts of the
demonstration project was inadvertently
omitted. The notice of a new system of
records will be republished at a later
date with the routine use included.
FOR FURTHER INFORMATION CONTACT:
Inquiries may be directed to: CMS
Privacy Officer, Division of Privacy
Compliance, Enterprise Architecture
and Strategy Group, Office of
PO 00000
Frm 00019
Fmt 4703
Sfmt 4703
Information Services, CMS, Room N2–
04–27, 7500 Security Boulevard,
Baltimore, Maryland 21244–1850. He
can also be reached at 410–786–5357 or
by e-mail at walter.stone@cms.hhs.gov.
Dated: July 18, 2007.
William Saunders,
Acting Deputy Director, Office of Information
Services, Centers for Medicare & Medicaid
Services.
[FR Doc. E7–14631 Filed 7–27–07; 8:45 am]
BILLING CODE 4120–03–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Assuring Radiation Protection;
Cooperative Agreement; Request for
Applications: RFA-FDA-CDRH–07–004;
Catalog of Federal Domestic
Assistance Number: 93.103
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
I. Funding Opportunity Description
The Food and Drug Administration
(FDA) is announcing its intention to
receive and consider applications for
the award of a cooperative agreement in
fiscal year 2007 (FY07) to provide
support in furtherance of FDA’s
responsibilities, under section 532 of
the Federal Food, Drug, and Cosmetic
Act (21 U.S.C. 360ii), to establish and
carry out a comprehensive radiation
control program. An estimated amount
of support in FY07 will be for up to
$400,000, with an additional 5 years of
support, subject to the condition that in
addition to FDA funds, augmenting
funds are transferred to FDA from other
Federal agencies to fully support this
program. Funds may not be used to fund
or conduct international activities or
initiatives. As the lead Federal agency,
FDA intends to collect funds from all
other contributing Federal agencies
through Interagency Agreements and
fund one award for up to $400,000 in
total costs (including both direct and
indirect costs). After the first year,
additional years of noncompetitive
support are predicated upon acceptable
performance during the preceding year
and the availability of Federal funds.
The cooperative agreement will allow
FDA to continue to work with the
Nuclear Regulatory Commission and its
predecessor organizations, the
Environmental Protection Agency and
the Federal Emergency Management
Agency, to provide financial support for
a forum established to foster the
exchange of ideas and information
E:\FR\FM\30JYN1.SGM
30JYN1
]]>Agencies
[Federal Register Volume 72, Number 145 (Monday, July 30, 2007)]
[Notices]
[Page 41510]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-3679]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality Notice of Meeting
In accordance with section 10(d) of the Federal Advisory Committee
Act (5 U.S.C., Appendix 2), announcement is made of a Health Care
Policy and Research Special Emphasis Panel (SEP) meeting.
A Special Emphasis Panel is a group of experts in fields related to
health care research who are invited by the Agency for Healthcare
Research and Quality (AHRQ), and agree to be available, to conduct on
an as needed basis, scientific reviews of applications for AHRQ
support. Individual members of the Panel do not attend regularly-
scheduled meetings and do not serve for fixed terms or a long period of
time. Rather, they are asked to participate in particular review
meetings which require their type of expertise.
Substantial segments of the upcoming SEP meeting listed below will
be closed to the public in accordance with the Federal Advisory
Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 552b
(c)(6). Grant applications for the Announcement of Availability of
Funds for Grants regarding Minority Research Infrastructure Support
Program (M-RISP) applications are to be reviewed and discussed at this
meeting. These discussions are likely to reveal personal information
concerning individuals associated with the applications. This
information is exempt from mandatory disclosure under the above-cited
statutes.
SEP Meeting on: Minority Research Infrastructure Support Program
(M-RISP).
Date: August 23, 2007 (Open on August 23 from 2 p.m to 2:15 p.m.
and closed for the remainder of the meeting).
Place: John M. Eisenberg Building, AHRQ Conference Center, 540
Gaither Road, Rockville, Maryland 20850.
Contact Person: Anyone wishing to obtain a roster of members,
agenda or minutes of the non-confidential portions of this meeting
should contact Mrs. Bonnie Campbell, Committee Management Officer,
Office of Extramural Research, Education and Priority Populations,
AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone
(301) 427-1554.
Agenda items for this meeting are subject to change as priorities
dictate.
Dated: July 23, 2007.
Carolyn M. Clancy,
Director.
[FR Doc. 07-3679 Filed 7-27-07; 8:45 am]
BILLING CODE 4160-90-M
